ATLANTA--(BUSINESS WIRE)--Impact Cryotherapy announced today the issuance to it by the US Patent & Trademark Office of a broad patent that covers the fundamental features of its innovative cryotherapy chambers. This patent covers Impact’s industry leading cryo chambers and their unique internal processes.
Under the patent the company is afforded protection for its innovative technology related to the unique delivery of nitrogen gas that allows for rapid pre-cooling of the cryotherapy chamber. Additionally, the patent claims cover several aspects of the cryo chamber's unique safety features. These features allow for safe and efficient operations during a cryotherapy session.
“We entered the market four years ago by first developing a product that set new standards in terms of its innovative design and safety. We became the US market leader in large part because of the quality of our engineering, which is now protected by this patent, which we believe will be the first of many,” said Richard E. Otto, President and CEO, Impact Cryotherapy. “Over 500 Impact Cryotherapy cryo chambers have been sold in the US and internationally. The issuance of this patent will help assure the protection of our proprietary design and technology,” Mr. Otto said.
Impact Cryotherapy also has additional patents pending covering other aspects of the company’s innovative and leading cryotherapy chambers and related processes.
About Impact Cryotherapy
Impact Cryotherapy is the market leader industry in cryotherapy chamber safety and innovation. Impact sets the standard for quality, certification, service and support for cryotherapy equipment. For further information on Impact Cryotherapy, please visit [https://impactcryo.com/].